Skip to main content
SpringerLink
Log in

Characteristics and quality of adverse drug reaction reporting: a comparison of pharmacists with other healthcare providers at a multi-specialty hospital in Qatar

  • Short Communication
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Objective

Rumailah Hospital (RH) is a multi-specialty hospital with a capacity of 605 beds that serves subacute and long-term patients in Qatar. Since under-reporting and low-quality reporting of adverse drug reactions (ADRs) are widespread phenomena globally, there is a need for greater insight into pharmacists’ and other healthcare professionals’ roles in ADR reporting in RH. Thus, this study primarily aimed to compare the number, quality, and characteristics of ADR reports received from pharmacists compared with other healthcare providers at RH in Qatar.

Methods

A retrospective descriptive analysis of ADR reports submitted by healthcare providers at RH between January 1, 2012 and October 1, 2014 was conducted.

Results

A total of 92 ADR reports were submitted by different healthcare providers, of which 42.8% were by pharmacists, 38.4% by physicians, and 8.8% by nurses. Most of the physicians’ (65.7%), nurses’ (62.5%), and pharmacists’ (41.0%) ADR reports were judged to be of high quality (grade 2) based on the World Health Organization’s quality scheme (p > 0.05). A causality assessment using the Naranjo algorithm revealed that 62.2% of the reports were ‘possibly’ caused by the suspected medications, while 31.1% were considered to ‘probably’ have been caused by the suspected medications (p < 0.05). Furthermore, most of the ADR reports were type B (54.9%) and unpreventable (64.8%) according to the Medication Appropriateness Index. One hundred percent and 91.2% of nurses’ and physicians’ ADR reports were for unpreventable events, respectively, while 41.0% of pharmacists’ reports were for definitely preventable ADRs (p < 0.05).

Conclusions

ADR reporting at RH was undertaken by different healthcare professionals, and a high proportion of the reports were judged to be of high quality. ADRs reported were often unpreventable. There were differences between the characteristics and causality scores of ADR reports between different healthcare professionals. There is a need to develop interventions that will further increase ADR reporting as well as the quality of the reports.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969–2002: the importance of reporting suspected reactions. Arch Intern Med. 2005;165:1363–9.

    Article  PubMed  Google Scholar 

  2. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions. JAMA. 1999;281:824.

    Article  CAS  PubMed  Google Scholar 

  3. Shepherd G, Mohorn P, Yacoub K, et al. Adverse drug reaction deaths reported in United States vital statistics, 1999–2006. Ann Pharmacother. 2012;46:169–75.

    Article  PubMed  Google Scholar 

  4. Miguel A, Azevedo LF, Araújo M, et al. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2012;21:1139–54.

    Article  PubMed  Google Scholar 

  5. Martins ACM, Giordani F, Rozenfeld S. Adverse drug events among adult inpatients: a meta-analysis of observational studies. J Clin Phar Ther. 2014;39:609–20.

    Article  CAS  Google Scholar 

  6. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995;155:1949–56.

    Article  CAS  PubMed  Google Scholar 

  7. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29:385–96.

    Article  PubMed  Google Scholar 

  8. Bandekar MS, Anwikar SR, Kshirsagar NA. Quality check of spontaneous adverse drug reaction reporting forms of different countries. Pharmacoepidemiol Drug Saf. 2010;19:1181–5.

    Article  CAS  PubMed  Google Scholar 

  9. de Jong-Van Grootheest AC, van den Berg LTW. The role of hospital and community pharmacists in pharmacovigilance. Res Soc Adm Pharm. 2005;1:126–33.

    Article  Google Scholar 

  10. Van Grootheest K, Olsson S, Couper M, et al. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13:457–64.

    Article  PubMed  Google Scholar 

  11. Baniasadi S, Habibi M, Haghgoo R, et al. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. IJPR. 2014;13:291–7.

    PubMed  PubMed Central  Google Scholar 

  12. Gedde-Dahl A, Harg P, Stenberg-Nilsen H, et al. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol Drug Saf. 2007;16:999–1005.

    Article  PubMed  Google Scholar 

  13. Wilbur K. Pharmacovigilance in Qatar Hospitals. Pharm Med. 2012;26:23–5.

    Google Scholar 

  14. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the Medication Appropriateness Index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994;47:891–6.

    Article  CAS  PubMed  Google Scholar 

  15. WHO. Uppsala Monitoring Centre [internet]. 2015 [cited 2015 Aug 9]. http://www.who-umc.org/DynPage.aspx?id=100653&mn1=7347&mn2=7252&mn3=7322&mn4=7442.

  16. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.

    Article  CAS  PubMed  Google Scholar 

  17. Ahmad SR, Freiman JP, Graham DJ, et al. Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA. Pharmacoepidemiol Drug Saf. 1996;5:1–7.

    Article  CAS  PubMed  Google Scholar 

  18. Medicines and Healthcare Products Regulatory Agency. Guidance on adverse drug reactions [internet]. 2015 [cited 2016 Jun 19]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/403098/Guidance_on_adverse_drug_reactions.pdf.

  19. Marja Hakkarainen K, Andersson Sundell K, Petzold M, et al. Methods for assessing the preventability of adverse drug events: a systematic review. Drug Saf. 2010;2:105–26.

    Google Scholar 

  20. Kanjanarat P, Winterstein AG, Johns T, et al. Nature of preventable adverse drug events in hospitals: a literature review. Am J Heal Pharm. 2003;60:1750–9.

    Google Scholar 

  21. Morimoto T, Gandhi TK, Seger AC, et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Heal Care. 2004;13:306–14.

    Article  CAS  Google Scholar 

  22. Mansur JM. Medication safety systems and the important role of pharmacists. Drugs Aging. 2016;33:213–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar

    Noor Alsalimy & Mohamed Magdy

  2. College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar

    Dana Elkhalifa, Aya Al Shammaa & Ahmed Awaisu

Authors
  1. Noor Alsalimy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dana Elkhalifa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aya Al Shammaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohamed Magdy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmed Awaisu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed Awaisu.

Ethics declarations

Funding

This study was supported by Qatar University under a student grant (Grant No. QUST-CPH-FALL-14/15-17).

Conflict of interest

All the authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alsalimy, N., Elkhalifa, D., Shammaa, A.A. et al. Characteristics and quality of adverse drug reaction reporting: a comparison of pharmacists with other healthcare providers at a multi-specialty hospital in Qatar. Drugs Ther Perspect 33, 283–289 (2017). https://doi.org/10.1007/s40267-017-0404-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-017-0404-z

Keywords

Search

Navigation